OR WAIT null SECS
February 28, 2024
A Carrum Health/PWC report surveys benefit managers spanning various self-insured employers in an effort to determine ways to improve the cancer treatment experience, especially from a cost perspective.
In an interview with Pharma Commerce Associate Editor Don Tracy, Corey Ford, VP, Reimbursement, Policy Insights, Cencora, provides a look at his recent webinar focused on the implications of the Inflation Reduction Act.
February 27, 2024
An investigation evaluates whether SNAP benefits can also influence hypertension patients’ lack of medication adherence.
February 23, 2024
The CRO’s FortreaRx doubles in size, including a boost in cold chain storage, while also continuing to improve its patient access services.
February 21, 2024
Cabenuva (cabotegravir + rilpivirine) showed superior efficacy in maintaining viral load suppression in patients with HIV compared with standard of care daily oral antiretroviral treatment.
February 14, 2024
Properly supporting market access for a newly launched product with a single indication is challenging. Doing so for multiple indications, or supporting subsequent indications, can have a compounding effect on the degree of difficulty for getting everything right.
February 12, 2024
Cohort study explores value-based insurance designs, while also determining how one’s place of residency can potentially play a role.
February 09, 2024
Researchers explore the proportion of approved drugs in the Canadian marketplace that utilize manufacturer-sponsored patient support programs, along with the types of medications that are more likely to do so.
February 05, 2024
And the need to boost awareness of this critical healthcare resource.
February 01, 2024
Health Affairs study investigates the consequences of patient medication abandonment surrounding oral HIV pre-exposure prophylaxis.